0001104659-16-151423.txt : 20161024 0001104659-16-151423.hdr.sgml : 20161024 20161024060127 ACCESSION NUMBER: 0001104659-16-151423 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20160930 FILED AS OF DATE: 20161024 DATE AS OF CHANGE: 20161024 EFFECTIVENESS DATE: 20161024 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Versant Venture Management, LLC CENTRAL INDEX KEY: 0001560009 IRS NUMBER: 954767945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16849 FILM NUMBER: 161947165 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-7877 MAIL ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001560009 XXXXXXXX 09-30-2016 09-30-2016 false Versant Venture Management, LLC
One Sansome Street, Suite 3630 San Francisco CA 94104
13F HOLDINGS REPORT 028-16849 N
Robin L. Praeger Managing Director, Versant Venture Management, LLC (415) 801-8100 /s/ Robin L. Praeger San Francisco CA 10-20-2016 0 7 89691641 false
INFORMATION TABLE 2 a16-20248_1informationtable.xml INFORMATION TABLE Clovis Oncology, Inc. Common Stock 189464100 14687347 407416 SH OTR 0 407416 0 CymaBay Therapeutics, Inc. Common Stock 23257D103 2034286 1048601 SH OTR 0 1048601 0 Achaogen, Inc. Common Stock 004449104 6136718 1281152 SH OTR 0 1281152 0 Ocular Therapeutix, Inc. Common Stock 67576A100 15219688 2215384 SH OTR 0 2215384 0 Glaukos Corporation Common Stock 377322102 2695693 71428 SH OTR 0 71428 0 Audentes Therapeutics, Inc. Common Stock 05070R104 32179678 1806832 SH OTR 0 1806832 0 Immune Design Corp. Common Stock 45252L103 16738232 2208210 SH OTR 0 2208210 0